Sort
82,697 grants matching “vaccine development”
An RSV Prefusion F Vaccine that Overcomes Immunosenescence
$939,591Mark Yondola · Calder Biosciences, Inc. · R44 · FY2020 · AG
Seattle Vaccine Trials Unit
$939,387Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI
Optimization and Advanced Proof-of-Concept Studies of a Listeria-vectored Multi-Antigenic Vaccine against Tuberculosis
$939,379Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2019 · AI
UCB/UCSF AIDS International Training and Research Program (AITRP)
$939,335Arthur L. Reingold · University Of California Berkeley · D43 · FY2010 · TW
Clinical-Virology Core
$939,238Kari C. Nadeau · Stanford University · U54 · FY2020 · CA
Project 3: T Cells
$939,232Mark M Davis · Stanford University · U54 · FY2020 · CA
Mechanisms and Duration of Immunity to SARS-CoV-2 - Supplement Application for Sept 2024-Aug 2025
$939,222Scott Dexter Boyd · Stanford University · U54 · FY2024 · CA
Durable HIV Vaccine Targeting Mucosal Epithelium
$939,000Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2023 · AI
Advanced Mass Spectrometry Facility
$938,947David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2009 · DK
STAMPOUT: A Phase 2a Study of Antibody for Methamphetamine Outpatient Therapy
$938,893Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2019 · DA
Vaccine development and production
$938,754Sylvain Fleury · University Of Louisiana At Lafayette · U19 · FY2020 · AI
Research Project 4: Mining human antibody responses to inform vaccine and therapeutic design
$938,732Jimmy D Gollihar · Albert Einstein College Of Medicine · U19 · FY2025 · AI
Annual Estimates of Influenza Vaccine Effectiveness: Davidson County, TN
$938,699Marie R Griffin · Vanderbilt University · U18 · FY2008 · IP
Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer
$938,597Christopher D Pack · Metaclipse Therapeutics Corporation · R44 · FY2022 · CA
Pediatric Clinical Research Scholar Program - Washington
$938,566Children'S Research Institute · K12 · FY2003 · RR
Advance Veterinary Services
$938,044Slobodan Paessler · University Of Texas Med Br Galveston · UC7 · FY2007 · AI
Emerging and High Risk Pathogens
$938,044Michael R Holbrook · University Of Texas Med Br Galveston · UC7 · FY2007 · AI
CCR Genomics Core
$937,890Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
The connection of innate and adaptive anti-cancer immunity
$937,885John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
MOLECULAR AND CELLULAR PATHOGENESES OF URINARY INFECTION
$937,693University Of Maryland Baltimore · P01 · FY2002 · DK
Project 3 - Flavivirus - UTMB
$937,499Pei-Yong Shi · University Of Alabama At Birmingham · U19 · FY2022 · AI
Project 2 - Novel Therapeutics for Emerging Alphavirus
$937,499Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2022 · AI
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses
$937,397John H Eldridge · Profectus Biosciences, Inc. · R01 · FY2014 · AI
ADOLESCENT MEDICINE TRIALS UNIT (AMTU)
$937,358Mount Sinai School Of Medicine Of Nyu · U01 · FY2005 · HD
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart
$937,341Venigalla B. Rao · Catholic University Of America · R01 · FY2018 · AI